Copy
View this email in your browser

Updates: COVID and Beyond


The eighth in a series of moderated UCSF Town Halls reviewing our current understanding of how COVID-19 might impact people living with Multiple Sclerosis and other autoimmune diseases of the central nervous system.

Wednesday, October 12, 2022
5:30-6:30pm (PDT)

Advance Registration 

To secure your spot, please register in advance. After registering, you’ll receive a confirmation email containing information about joining the webinar.

Submitting Questions

While live questions will be allowed via Zoom, we invite you to submit questions beforehand using the provided link below:
SUBMIT A QUESTION
Click Here to Register for the Zoom Webinar

Facilitator and Speaker


Ari Green, MD, MCR
Professor of Neurology and Ophthalmology
Division Chief, Neuroimmunology and Glial Biology
Director, UCSF Multiple Sclerosis and Neuroinflammation Center 
Director, Neurodiagnostic Center
 

INVITED SPEAKER

The Immunogenetics of COVID-19:
Understanding Asymptomatic Infection

 

Jill Hollenbach, PhD, MPH

Professor, Division of Neuroimmunology and Glial Biology
Departments of Neurology and Epidemiology and Biostatistics


Jill Hollenbach is Professor in the Department of Neurology and Department of Epidemiology and Biostatistics at the University of California, San Francisco. She was raised in California and completed her undergraduate studies in Physiology and Master’s degree in Public Health at the University of California, Berkeley. After several years working in public health in the Caribbean and Bay Area, she returned to UC Berkeley for her doctoral studies in Immunology, with an emphasis on population genetics of the human leukocyte antigen (HLA) system. Throughout her career Dr. Hollenbach’s work has continued to focus on the HLA loci and related systems such as the killer immunoglobulin-like receptor (KIR) genes in disease association, transplantation and evolutionary studies. She has also been deeply involved in the establishment of community standards and software development for immunogenetic data management and analysis and is a Councilor of the International HLA and Immunogenetics Council and Associate Editor for disease association studies at HLA Journal. Dr. Hollenbach’s laboratory at UCSF applies study of these complex systems to advance efforts to elucidate the genetic basis of underlying immune dysregulation in neurological, autoimmune, and infectious disease.
 

 

Additional Topics to Be Covered


Bivalent Vaccine

Sonam Dilwali, MD, PhD
Clinical Fellow in Neuroimmunology
 

Evusheld Re-dosing, Paxlovid and Rebounding Symptoms

Steven Merrill, PharmD, MSCS
Assistant Professor of Clinical Pharmacy
Neurology Clinical Pharmacist
 

General Vaccine Updates

Joanne Guo, MD
Assistant Professor of Clinical Neurology
Lead Clinical Provider
 

Infusion Center Opening at the Weill Neurosciences Building

Lauren Oommen, DO
Assistant Professor of Clinical Neurology
Lead Clinical Provider II 

Steven Hong, PharmD, BCPS
Infusion Pharmacist
 

Participating members of the UCSF MS and Neuroinflammation Center Leadership Team:
Joanne Guo, MD

Jeff Gelfand, MD
, MAS
Lauren Oommen, DO
Valerie Block, PT, DPTSc

Sirin Tgamol, Administrative Director
Steven Merrill, PharmD, MSCS

Steven Hong, PharmD, BCPS
Alicia Mallory, RN
Cuquita O'Shea, BS, BA, CCRP

Robin Lincoln, BS

Amy Schwartzburg, NP
Marianne Doyle, LCSW

And the UCSF MS and Neuroinflammation Center Fellows:
Ahmed Abdelhak, MD
Sonam Dilwali, MD, PhD
Josiah Gerdts, MD, PhD
Martineau Louine, MD

Carson Moseley, MD
, PhD
Alyssa Nylander, MD, PhD
Akash Virupakshaiah, MD

Contact Information

For patient concerns, please contact your physician’s office. The UCSF Multiple Sclerosis & Neuroinflammation Center can be reached at (415)353-2069 or message your provider through UCSF MyChart.

For general/non-clinical inquiries, or technical questions related to the webinar, please email ngb@ucsf.edu in advance. 

For any questions you’d like answered during the Town Hall, please refer to the ‘SUBMIT A QUESTION’ link provided above.